Table 2.
Social Area (SA) | Buprenorphine 2004–2013 | Methadone 2004–2011 | 2011–2013 | |||
---|---|---|---|---|---|---|
Slope | Sig. | Slope | Sig | Slope | Sig. | |
1 (L, L, L) | 1.51 | * | −0.45 | * | 0.73 | * |
2 (M,L,L) | 1.28a | * | −1.00c | * | 2.22 | * |
3 (M,H,L) | 0.77b | * | −0.94c | * | 4.98e | * |
4 (M,L,H) | 0.75b | * | −0.90 | * | 1.81 | |
5.(H,M,H) | 1.62 | * | −2.60d | * | 8.33f | * |
Pairwise contrast significant using Bonferroni adjustment to account for 10 comparisons, p < 0.005.
2 < 5.
(3,4) < (1,2,5).
(2,3) < 1.
5 < (1,2,3,4).
3 > (1,2,4).
5 > (1,2,3,4).
Slope significant using Bonferroni adjustment to account for 5 tests, p < 0.01.